Exero Medical

About Exero Medical

Exero Medical is dedicated to improving post-operative care by providing actionable insights through tissue healing data. Their mission is to empower healthcare providers with high-quality data from surgical sites to save lives, improve patient prognosis, and reduce care costs.

Products & Services

xBar System:A system for early, accurate, and non-invasive detection of post-operative complications like anastomotic leaks after gastrointestinal surgery, enabling earlier intervention to minimize morbidity, mortality, and costs. Currently limited to investigational use and not approved for sale in the US.

Specialties

Post-operative monitoring Early detection of surgical complications Gastrointestinal surgery solutions Non-invasive diagnostic technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 12700000 MR: - FA: up to $12.7M FAN: 12700000	D: 2025-02-13 FD: 2025-02-13	3 investors

Seed Latest

2025-02-13

$12.7M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Erez Shor, PhD

CEO

I

Ilana Fishman

VP Regulatory and Clinical Operations

G

Gilad Lerman, PhD

VP R&D

M

Matan Ben David, MD

Medical Director, Founder, Board Member

N

Noam Taichler, CPA, MBA

CFO

E

Eileen Ke

VP Business Development

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Exero Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised